PART 1 IMMUNOLOGY1.1 Pathophysiology of atopic excema in humans1.2 Mechanism of lesion formation in canine atopic dermatitis: 2004 hypothesis1.3 Expression of Th1-cytokine mRNA in canine atopic dermatitis correlates with severity of clinical lesions1.4 IgE and IgG antibodies to food antigens in sera from normal dogs, dogs with atopic dermatitis and dogs with adverse food reactions1.5 Evaluation of a rapid, quantitative, allergen-specific IgE screening immunoassay in dogs with atopic dermatitis1.6 Comparison of intradermal testing and allergen-specific IgE serum testing in dogs with warm-weather, seasonal atopic dermatitis1.7 Patch test reactions to house dust mites in dogs with atopic dermatitis1.
8 ?1.9 Dermatophagoides farinae-specific IgG subclass responses in atopic dogs undergoing allergen-specific immunotherapy1.10 Effect of treatment with recombinant canine IFn on the clinical signs, histopathology, and Th1 / Th2-cytokine mRNA profiles in Shih tzu dogs and a basset hound with atopic dermatitis1.11 Effects of the immunomodulatory drugs tacrolimus, rapamycin, and cilomilast on dendritic cell function in a rodent model of allergic contact dermatitis1.12 Temporal development on ovine cutaneous hypersensitivity responses to Psoroptes ovis (sheep scab mite)PART 2 THERAPY2.1 Immunomodulatory Therapy2.2 Lufenuron does not augment effectiveness of terbinafine for treatment of Microsporum canis infections in a feline model2.3 An overview of pharmacokinetic and pharmacodynamic studies in the development of itraconazole for feline Microsporum canis dermatophytosis2.
4 Evaluation of cephalexin intermittent therapy (weekend therapy) in the control of recurrent idiopathic pyoderma in dogs: a randomised, double-blinded, placebo-controlled study2.5 Comparison of bacterial organisms from otic exudates and ear tissue from the middle ear of untreated and enrofloxacin-treated dogs with end-stage otitis2.6 ?2.7 Diagnosis and treatment of pituitary pars intermedia dysfunction (classical Cushing's disease) and metabolic syndrome (peripheral Cushing's syndrome) in horsesPART 3 NUTRITION3.1 A randomised, controlled, double-blinded, multicentre study on the efficacy of a diet rich in fish oil and borage oil in the control of canine atopic dermatitisPART 4 SKIN BIOLOGY4.1 ?4.2 Optical biopsy: non-invasive tissue evaluation utilising optical coherence tomography4.3 Influence of purinergic substances on proliferation of murine keratinocytes and full-thickness skin healing4.
4 Factors associated with Malassezia colonisation in the ear canals of dogs without clinical signs of otitis externaPART 5 INFECTIOUS AND PARASITIC DISEASES5.1 Mycobacterial diseases of cats and dogs5.2 ?5.3 Rhodococcus spp. as ubiquitous contaminants of paraffin-embedded tissues in PCR analysis for Mycobacterium spp. skin infections5.4 In Vivo mRNA expression analysis of Microsporum canis secreted subtilisin-like serine proteases in feline dermatophytosis5.5 Real-time PCR for monitoring cutaneous asymptomatic carriage of Leishmania spp.
in laboratory mice5.6 Adherence of Staphylococcus intermedius to canine corneocytes involves a protein-protein interaction that is sensitive to trypsin, but resistant to cold5.7 Retrospective histopathological and clinical characterisation of a dermatopathy associated with toxic shock-like syndrome in dogsPART 6 WORKSHOPS6.1 Canine Hypothyroidism6.2 Leishmaniasis and other arthropod-vectored diseases6.3 Parasites and antiparasitic drugs6.4 Anti-fungal therapy6.5 New developments in dermatopathological diagnosis6.
6 Pseodomonas otitis6.7 Neoplastic and paraneoplastic skin diseases6.8 Food allergy: hydrolysed vs. limited-antigen diets6.9 New forms of therapy for atopic dermatitis6.10 Equine allergic disease6.11 Genodermatosis: alopecia and hypothricoses6.12 Therapy of recurrent pyoderma and immunostimulants6.
13 Rodent and rabbit dermatology6.14 Shampoos and topical therapy.